Bristol-Myers Squibb will not pursue early FDA filing for its Opdivo plus Yervoy combination in first line lung cancer – news which sent shares down more than 10% on Friday.
Eleven new digital health start-ups have graduated from PharmStars’ twice-yearly education and mentoring programme, with the latest crop focusing on digital innovations in
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio